Switch to:
Isis Pharmaceuticals (NAS:ISIS)
EV/EBITDA
-113.52 (As of Today)

EV/EBITDA ratio is calculated as enterprise value divided by its EBITDA. As of today, Isis Pharmaceuticals's enterprise value is $7,332.6 Mil. Isis Pharmaceuticals's earnings before depreciation and amortization for the trailing twelve months (TTM) ended in Sep. 2014 was $-64.6 Mil. Therefore, Isis Pharmaceuticals's EV/EBITDA ratio for today is -113.52.

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

As of today, Isis Pharmaceuticals's stock price is $65.09. Isis Pharmaceuticals's earnings per share for the trailing twelve months (TTM) ended in Sep. 2014 was $-0.81. Therefore, Isis Pharmaceuticals's P/E Ratio for today is .

The "classic" EV/EBITDA ratio is much better in capturing debt and net cash than the P/E Ratio.


Definition

Isis Pharmaceuticals's EV/EBITDA for today is calculated as:

EV/EBITDA=Enterprise Value (Today)/Earnings Before Depreciation and Amortization (TTM)
=7332.578/-64.591
=-113.52

Isis Pharmaceuticals's current Enterprise Value is $7,332.6 Mil.
Isis Pharmaceuticals's Earnings Before Depreciation and Amortization for the trailing twelve months (TTM) ended in Sep. 2014 was -16.503 (Dec. 2013 ) + -26.318 (Mar. 2014 ) + -3.909 (Jun. 2014 ) + -17.861 (Sep. 2014 ) = $-64.6 Mil.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.


Explanation

EV/EBITDA (Enterprise value/EBITDA) is a valuation multiple used in finance and investment to measure the value of a company. This important multiple is often used in conjunction with, or as an alternative to, the P/E Ratio to determine the fair market value of a company.

Isis Pharmaceuticals's P/E Ratio for today is calculated as:

P/E Ratio=Share Price (Today)/Earnings Per Share (TTM)
=65.09/-0.809
=

Isis Pharmaceuticals's share price for today is $65.09.
Isis Pharmaceuticals's Earnings Per Share for the trailing twelve months (TTM) ended in Sep. 2014 was -0.209 (Dec. 2013 ) + -0.27 (Mar. 2014 ) + -0.1 (Jun. 2014 ) + -0.23 (Sep. 2014 ) = $-0.81.

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Study has found that the companies with the lowest EV/EBITDA outperforms companies measured as cheap by other ratios such as P/E Ratio.

Please read Which price ratio outperforms the enterprise multiple?


Related Terms

Enterprise Value, Earnings Before Depreciation and Amortization, P/E Ratio


Historical Data

* All numbers are in millions except for per share data and ratio. All numbers are in their own currency.

Isis Pharmaceuticals Annual Data

Dec04Dec05Dec06Dec07Dec08Dec09Dec10Dec11Dec12Dec13
ev2ebitda -4.08-7.55-12.58-41.17-405.07-35.36-14.35-6.69-14.37-108.64

Isis Pharmaceuticals Quarterly Data

Jun12Sep12Dec12Mar13Jun13Sep13Dec13Mar14Jun14Sep14
ev2ebitda -21.20-21.03-14.37-53.45-73.13-144.22-108.64-67.49-53.41-65.25
Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK